Webinar
What does it take to bring a first-in-class cell therapy from exploratory studies to a Phase 3 trial in the U.S.—efficiently, compliantly, and without unnecessary complexity?
In this webinar, Christian, Sabrina and Derk will walk through the clinical journey behind Gameto’s fertility treatment platform. You’ll hear how the team ran nine global studies with a small, high-performing team—turning early data into FDA-cleared evidence for their pivotal trial.
They explore:
From study builds to monitoring workflows, Castor helped power Gameto’s clinical strategy—proving that the right tools and partnerships can unlock outsized impact.
Whether you’re leading clinical ops, digital health, or translational science, this conversation will offer practical insights for scaling research with speed and precision.
Watch on-demand now >
Join Christian Kramme, Chief Scientific Officer at Gameto, and Derk Arts, CEO of Castor, for a behind-the-scenes look at how a small team launched a global clinical program and reached Phase 3—fast.
Discover all the features offered by Castor EDC
Discover Now